Poultry Drugs Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012 to 2016 and Forecast 2017 to 2023
Global Poultry Drugs Market: By Product Type (Vaccines, Drugs, Feed Additives), By Drug Type (Antibiotics, Anti-gout Agents, Anthelmintic, Nutritional Supplements, Anti-infectives, Others) By Animal Type (Turkey, Chicken, Goose, Duck, Others), and Geography – Poultry Drugs Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012 to 2016 and Forecast 2017 to 2023
Market Dynamics: Poultry Drugs Market
Drugs are the chemical substances used to diagnose, treat, prevent, or cure the various diseases. Poultry drugs are used to prevent or cure the various poultry diseases such as infectious diseases, gout, helminthiasis, and nutritional disorders among others. Increase in the demand for healthy meat and poultry products, rise in prevalence of various infectious diseases such as avian influenza, rise in R&D activities for the innovation of newer drugs, and increase in animal healthcare expenditure are expected to bolster the poultry drugs market over the forecast period. Moreover, government initiations for protecting the poultry industry, innovation of newer drugs and vaccines, and increase in the number of poultry farms are expected to bolster the poultry drugs market. However, stringent regulatory guidelines for the product approval, adverse effects associated with drugs, lack of awareness about the poultry diseases in underdeveloped countries, and high R&D expenditure may impede the growth of poultry drugs market over the forecast years.
Market Scope: Global Poultry Drugs Market
This market is segmented on the basis of drug type, animal type, and region
Based on the drug type, the market is segmented into the following:
Parasiticides
Antibiotics
Anti-inflammatory Drugs
Others
Based on the animal type, this market is segmented into the following:
Turkey
Chicken
Goose
Duck
Others
Based on the region, This market is segmented into the following:
North America
Europe
Asia Pacific
Latin America
Middle East and Africa
Regional Analysis: Poultry Drugs Market
Geographically, global poultry drugs market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa regions. North America poultry drugs market is growing at a significant rate, which is attributed to rise in demand for healthy meat and poultry products, launching of newer products into the market, and increase in awareness about the poultry diseases. Europe poultry drugs market has a lucrative growth owing to rise in prevalence of various diseases such as avian flu, rise in animal welfare expenditure, and increase in the R&D activities for the innovation of newer drugs are bolster the market. Asia Pacific poultry drugs market is poised to grow at significant rate due to increase in trading of meat and other poultry products from India and China, rise in number of poultry farms, and adoption of newer drugs and vaccines. Latin America poultry drugs market is rising due to positive economic growth, rise in animal welfare expenditure, and launching of newer products by the companies in the region. Middle East and Africa poultry drugs market exhibiting a prominent growth rate owing to expansion of business by the market players, rise in prevalence of infectious diseases, and increase in awareness about poultry diseases are boost the market.
Competition Assessment: Poultry Drugs Market
Key players profiles in the global poultry drugs market include:
Zoetis (Pfizer, Inc.) (U.S.)
Merck & Co. Inc. (U.S)
Virbac S.A. (France)
Boehringer Ingelheim Vetmedica (Germany)
Elanco (U.S.)
Bayer Animal Health (Germany)
Phibro Animal health Corporation (U.S.)
Zydus AHL (India)
Ceva Sante Animale (France)
Notable Market Developments: Poultry Drugs Market
In May 2016, Elanco launched Inteprity (avilamycin) for the prevention of necrotic enteritis in broiler chickens
Key Features of the Report:
The report provides granular level information about the market size, regional market share, historic market (2012-2016) and forecast (2017-2023)
The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
The report tracks recent innovations, key developments and startup’s details that are actively working in the market
The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market
Market Dynamics: Poultry Drugs Market
Drugs are the chemical substances used to diagnose, treat, prevent, or cure the various diseases. Poultry drugs are used to prevent or cure the various poultry diseases such as infectious diseases, gout, helminthiasis, and nutritional disorders among others. Increase in the demand for healthy meat and poultry products, rise in prevalence of various infectious diseases such as avian influenza, rise in R&D activities for the innovation of newer drugs, and increase in animal healthcare expenditure are expected to bolster the poultry drugs market over the forecast period. Moreover, government initiations for protecting the poultry industry, innovation of newer drugs and vaccines, and increase in the number of poultry farms are expected to bolster the poultry drugs market. However, stringent regulatory guidelines for the product approval, adverse effects associated with drugs, lack of awareness about the poultry diseases in underdeveloped countries, and high R&D expenditure may impede the growth of poultry drugs market over the forecast years.
Market Scope: Global Poultry Drugs Market
This market is segmented on the basis of drug type, animal type, and region
Based on the drug type, the market is segmented into the following:
Parasiticides
Antibiotics
Anti-inflammatory Drugs
Others
Based on the animal type, this market is segmented into the following:
Turkey
Chicken
Goose
Duck
Others
Based on the region, This market is segmented into the following:
North America
Europe
Asia Pacific
Latin America
Middle East and Africa
Regional Analysis: Poultry Drugs Market
Geographically, global poultry drugs market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa regions. North America poultry drugs market is growing at a significant rate, which is attributed to rise in demand for healthy meat and poultry products, launching of newer products into the market, and increase in awareness about the poultry diseases. Europe poultry drugs market has a lucrative growth owing to rise in prevalence of various diseases such as avian flu, rise in animal welfare expenditure, and increase in the R&D activities for the innovation of newer drugs are bolster the market. Asia Pacific poultry drugs market is poised to grow at significant rate due to increase in trading of meat and other poultry products from India and China, rise in number of poultry farms, and adoption of newer drugs and vaccines. Latin America poultry drugs market is rising due to positive economic growth, rise in animal welfare expenditure, and launching of newer products by the companies in the region. Middle East and Africa poultry drugs market exhibiting a prominent growth rate owing to expansion of business by the market players, rise in prevalence of infectious diseases, and increase in awareness about poultry diseases are boost the market.
Competition Assessment: Poultry Drugs Market
Key players profiles in the global poultry drugs market include:
Zoetis (Pfizer, Inc.) (U.S.)
Merck & Co. Inc. (U.S)
Virbac S.A. (France)
Boehringer Ingelheim Vetmedica (Germany)
Elanco (U.S.)
Bayer Animal Health (Germany)
Phibro Animal health Corporation (U.S.)
Zydus AHL (India)
Ceva Sante Animale (France)
Notable Market Developments: Poultry Drugs Market
In May 2016, Elanco launched Inteprity (avilamycin) for the prevention of necrotic enteritis in broiler chickens
Key Features of the Report:
The report provides granular level information about the market size, regional market share, historic market (2012-2016) and forecast (2017-2023)
The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
The report tracks recent innovations, key developments and startup’s details that are actively working in the market
The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market
1. EXECUTIVE SUMMARY
2. GLOBAL POULTRY DRUGS MARKET INTRODUCTION
2.1. Global Poultry Drugs Market – Taxonomy
2.2. Global Poultry Drugs Market –Definitions
2.2.1. Drug Type
2.2.2. Poultry Type
3. GLOBAL POULTRY DRUGS MARKET DYNAMICS
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Poultry Drugs Market Dynamic Factors - Impact Analysis
3.6. Global Poultry Drugs Market – Regulations
3.6.1. U.S.
3.6.2. Europe
4. GLOBAL POULTRY DRUGS MARKET ANALYSIS, 2012 – 2016 AND FORECAST, 2017 – 2023
4.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Opportunity Analysis
5. GLOBAL POULTRY DRUGS MARKET ANALYSIS, BY DRUG TYPE, 2012 - 2016 AND FORECAST, 2017 – 2023 (REVENUE, USD MN)
5.1. Parasiticides
5.1.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. Antibiotics
5.2.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
5.3. Anti-inflammatory Drugs
5.3.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.3. Market Opportunity Analysis
5.4. Others
5.4.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.4.3. Market Opportunity Analysis
6. GLOBAL POULTRY DRUGS MARKET ANALYSIS, BY POULTRY TYPE, 2012 - 2016 AND FORECAST, 2017 – 2023
6.1. Turkey
6.1.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Chicken
6.2.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
6.3. Layers
6.3.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.3.3. Market Opportunity Analysis
6.4. Goose
6.4.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.4.3. Market Opportunity Analysis
6.5. Duck
6.5.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
6.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.5.3. Market Opportunity Analysis
6.6. Others
6.6.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
6.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.6.3. Market Opportunity Analysis
7. GLOBAL POULTRY DRUGS MARKET ANALYSIS, BY REGION, 2012 - 2016 AND FORECAST, 2017 – 2023 (REVENUE, USD MN)
7.1. North America
7.1.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Europe
7.2.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
7.3. Asia-Pacific
7.3.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.3.3. Market Opportunity Analysis
7.4. Latin America
7.4.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.4.3. Market Opportunity Analysis
7.5. Middle East and Africa
7.5.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.5.3. Market Opportunity Analysis
7.6. Global Poultry Drugs Market - Opportunity Analysis Index, By Drug Type, By Poultry Type, and Region, 2017 – 2023
8. NORTH AMERICA POULTRY DRUGS MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 – 2023 (REVENUE, USD MN)
8.1. Drug Type Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
8.1.1. Parasiticides
8.1.2. Antibiotics
8.1.3. Anti-inflammatory Drugs
8.1.4. Others
8.2. Poultry Type Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
8.2.1. Turkey
8.2.2. Chicken
8.2.3. Layers
8.2.4. Goose
8.2.5. Duck
8.2.6. Others
8.3. Country Analysis 2016 and Forecast 2017 – 2023 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
8.3.1. U.S.
8.3.2. Canada
8.4. North America Poultry Drugs Market - Opportunity Analysis Index, By Drug Type, By Poultry Type, and Country, 2017 – 2023
8.5. North America Poultry Drugs Market Dynamics – Trends
9. EUROPE POULTRY DRUGS MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 – 2023 (REVENUE, USD MN)
9.1. Country Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
9.1.1. Germany
9.1.2. UK
9.1.3. France
9.1.4. Spain
9.1.5. Italy
9.1.6. Russia
9.1.7. Poland
9.1.8. Rest of Europe
9.2. Europe Poultry Drugs Market - Opportunity Analysis Index, By Drug Type, By Poultry Type, and Country, 2017 – 2023
9.3. Europe Poultry Drugs Market Dynamics – Trends
10. ASIA-PACIFIC POULTRY DRUGS MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 – 2023 (REVENUE, USD MN)
10.1. Country Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
10.1.1. Japan
10.1.2. China
10.1.3. India
10.1.4. ASEAN
10.1.5. Australia & New Zealand
10.1.6. Rest of Asia-Pacific
10.2. Asia-Pacific Poultry Drugs Market - Opportunity Analysis Index, By Drug Type, By Poultry Type, and Country, 2017 – 2023
10.3. Asia-Pacific Poultry Drugs Market Dynamics – Trends
11. LATIN AMERICA POULTRY DRUGS MARKET ANALYSIS, 2012 - 2012 - 2012 - 2016 AND FORECAST, 2017 – 2023 (REVENUE, USD MN)
11.1. Country Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
11.1.1. Brazil
11.1.2. Mexico
11.1.3. Argentina
11.1.4. Venezuela
11.1.5. Rest of Latin America
11.2. Latin America Poultry Drugs Market - Opportunity Analysis Index, By Drug Type, By Poultry Type, and Country, 2017 – 2023
11.3. Latin America Poultry Drugs Market Dynamics – Trends
12. MIDDLE EAST AND AFRICA POULTRY DRUGS MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 – 2023 (REVENUE, USD MN)
12.1. Country Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
12.1.1. Gulf Cooperation Council (GCC) Countries
12.1.2. Israel
12.1.3. South Africa
12.1.4. Rest of MEA
12.2. MEA Poultry Drugs Market - Opportunity Analysis Index, By Drug Type, By Poultry Type, and Country, 2017 – 2023
12.3. MEA Poultry Drugs Market Dynamics – Trends
13. COMPETITION LANDSCAPE
13.1. Strategic Dashboard of Top Market Players
13.2. Company Profiles (Introduction, Financial Analysis, Product & Service Offerings, Key Developments, Strategies, and SWOT Analysis)
13.2.1. Zoetis (Pfizer, Inc.) (U.S.)
13.2.2. Merck & Co. Inc. (U.S)
13.2.3. Virbac S.A. (France)
13.2.4. Boehringer Ingelheim Vetmedica (Germany)
13.2.5. Elanco (U.S.)
13.2.6. Bayer Animal Health (Germany)
13.2.7. Phibro Animal health Corporation (U.S.)
13.2.8. Zydus AHL (India)
13.2.9. Ceva Sante Animale (France)
14. RESEARCH METHODOLOGY
15. KEY ASSUMPTIONS AND ACRONYMS
2. GLOBAL POULTRY DRUGS MARKET INTRODUCTION
2.1. Global Poultry Drugs Market – Taxonomy
2.2. Global Poultry Drugs Market –Definitions
2.2.1. Drug Type
2.2.2. Poultry Type
3. GLOBAL POULTRY DRUGS MARKET DYNAMICS
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Poultry Drugs Market Dynamic Factors - Impact Analysis
3.6. Global Poultry Drugs Market – Regulations
3.6.1. U.S.
3.6.2. Europe
4. GLOBAL POULTRY DRUGS MARKET ANALYSIS, 2012 – 2016 AND FORECAST, 2017 – 2023
4.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Opportunity Analysis
5. GLOBAL POULTRY DRUGS MARKET ANALYSIS, BY DRUG TYPE, 2012 - 2016 AND FORECAST, 2017 – 2023 (REVENUE, USD MN)
5.1. Parasiticides
5.1.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. Antibiotics
5.2.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
5.3. Anti-inflammatory Drugs
5.3.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.3. Market Opportunity Analysis
5.4. Others
5.4.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.4.3. Market Opportunity Analysis
6. GLOBAL POULTRY DRUGS MARKET ANALYSIS, BY POULTRY TYPE, 2012 - 2016 AND FORECAST, 2017 – 2023
6.1. Turkey
6.1.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Chicken
6.2.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
6.3. Layers
6.3.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.3.3. Market Opportunity Analysis
6.4. Goose
6.4.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.4.3. Market Opportunity Analysis
6.5. Duck
6.5.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
6.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.5.3. Market Opportunity Analysis
6.6. Others
6.6.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
6.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.6.3. Market Opportunity Analysis
7. GLOBAL POULTRY DRUGS MARKET ANALYSIS, BY REGION, 2012 - 2016 AND FORECAST, 2017 – 2023 (REVENUE, USD MN)
7.1. North America
7.1.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Europe
7.2.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
7.3. Asia-Pacific
7.3.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.3.3. Market Opportunity Analysis
7.4. Latin America
7.4.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.4.3. Market Opportunity Analysis
7.5. Middle East and Africa
7.5.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.5.3. Market Opportunity Analysis
7.6. Global Poultry Drugs Market - Opportunity Analysis Index, By Drug Type, By Poultry Type, and Region, 2017 – 2023
8. NORTH AMERICA POULTRY DRUGS MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 – 2023 (REVENUE, USD MN)
8.1. Drug Type Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
8.1.1. Parasiticides
8.1.2. Antibiotics
8.1.3. Anti-inflammatory Drugs
8.1.4. Others
8.2. Poultry Type Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
8.2.1. Turkey
8.2.2. Chicken
8.2.3. Layers
8.2.4. Goose
8.2.5. Duck
8.2.6. Others
8.3. Country Analysis 2016 and Forecast 2017 – 2023 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
8.3.1. U.S.
8.3.2. Canada
8.4. North America Poultry Drugs Market - Opportunity Analysis Index, By Drug Type, By Poultry Type, and Country, 2017 – 2023
8.5. North America Poultry Drugs Market Dynamics – Trends
9. EUROPE POULTRY DRUGS MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 – 2023 (REVENUE, USD MN)
9.1. Country Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
9.1.1. Germany
9.1.2. UK
9.1.3. France
9.1.4. Spain
9.1.5. Italy
9.1.6. Russia
9.1.7. Poland
9.1.8. Rest of Europe
9.2. Europe Poultry Drugs Market - Opportunity Analysis Index, By Drug Type, By Poultry Type, and Country, 2017 – 2023
9.3. Europe Poultry Drugs Market Dynamics – Trends
10. ASIA-PACIFIC POULTRY DRUGS MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 – 2023 (REVENUE, USD MN)
10.1. Country Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
10.1.1. Japan
10.1.2. China
10.1.3. India
10.1.4. ASEAN
10.1.5. Australia & New Zealand
10.1.6. Rest of Asia-Pacific
10.2. Asia-Pacific Poultry Drugs Market - Opportunity Analysis Index, By Drug Type, By Poultry Type, and Country, 2017 – 2023
10.3. Asia-Pacific Poultry Drugs Market Dynamics – Trends
11. LATIN AMERICA POULTRY DRUGS MARKET ANALYSIS, 2012 - 2012 - 2012 - 2016 AND FORECAST, 2017 – 2023 (REVENUE, USD MN)
11.1. Country Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
11.1.1. Brazil
11.1.2. Mexico
11.1.3. Argentina
11.1.4. Venezuela
11.1.5. Rest of Latin America
11.2. Latin America Poultry Drugs Market - Opportunity Analysis Index, By Drug Type, By Poultry Type, and Country, 2017 – 2023
11.3. Latin America Poultry Drugs Market Dynamics – Trends
12. MIDDLE EAST AND AFRICA POULTRY DRUGS MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 – 2023 (REVENUE, USD MN)
12.1. Country Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
12.1.1. Gulf Cooperation Council (GCC) Countries
12.1.2. Israel
12.1.3. South Africa
12.1.4. Rest of MEA
12.2. MEA Poultry Drugs Market - Opportunity Analysis Index, By Drug Type, By Poultry Type, and Country, 2017 – 2023
12.3. MEA Poultry Drugs Market Dynamics – Trends
13. COMPETITION LANDSCAPE
13.1. Strategic Dashboard of Top Market Players
13.2. Company Profiles (Introduction, Financial Analysis, Product & Service Offerings, Key Developments, Strategies, and SWOT Analysis)
13.2.1. Zoetis (Pfizer, Inc.) (U.S.)
13.2.2. Merck & Co. Inc. (U.S)
13.2.3. Virbac S.A. (France)
13.2.4. Boehringer Ingelheim Vetmedica (Germany)
13.2.5. Elanco (U.S.)
13.2.6. Bayer Animal Health (Germany)
13.2.7. Phibro Animal health Corporation (U.S.)
13.2.8. Zydus AHL (India)
13.2.9. Ceva Sante Animale (France)
14. RESEARCH METHODOLOGY
15. KEY ASSUMPTIONS AND ACRONYMS
